Paris-based BC Platforms (BCP) announced on June 1 that it acquired 4Pharma Ltd, a contract research organization (CRO).
4Pharma provides medical research services to pharmaceutical, biotechnology and medical device companies. 4Pharma was founded more than 20 years ago and has collaborations with approximately 70 clients in the Nordics, Central Europe and the US.
BC Platforms is a global leader in building data networks for the life sciences industry and provides versatile technology platforms for personalized medicine, accelerating the translation of innovations into clinical practice. In November 2022, Jolt Capital invested $20 million into BC Platforms.
The acquisition expands BCP’s global service offering for accelerating the translation of innovations into clinical practice. In addition, 4Pharma customers will benefit from additional services in the field of RWD through the BC Platform technology. The financial terms were not disclosed.
According to data captured in the LevinPro HC database, this transaction marks the 16th CRO transaction of the year. Per its website, this is BC Platforms’ first acquisition since receiving funding from Jolt Capital.
